In Canada, health product ads to the public may not claim to treat or cure Schedule A.1 diseases or exceed authorized claims, and prescription drug ads are limited to name, price and quantity.
Food and Drugs Act ss. 3, 9, Sch. A.1; FDR C.01.044
Canadian medical device ads must not make treatment or cure claims for Schedule A.1 diseases to the public, misrepresent Health Canada authorization, or make false or misleading claims.
Food and Drugs Act ss. 3, 20, Sch. A.1
Digital therapeutics and SaMD advertised in Canada may not be promoted to the public as treating, preventing or curing Schedule A.1 diseases, must not be advertised in a false or misleading way, and Class II-IV devices may not be advertised for sale before they are licensed.
Food and Drugs Act ss. 3, 20, Sch. A.1; Medical Devices Regulations s. 27
Canadian medical device ads must stay within the licensed indication, not be misleading, and not promote treatment, prevention or cure of Schedule A.1 diseases to the public.
Food and Drugs Act ss. 3, 20, Sch. A.1; MDR s. 27